Published in Cytokine Growth Factor Rev on August 01, 2004
Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma | NCT01545427
Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 8.89
Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis (2010) 4.24
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med (2006) 3.84
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med (2013) 3.35
Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol (2009) 2.78
Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle (2011) 2.41
Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol (2008) 2.32
Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol (2014) 2.29
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
c-Kit-negative fibroblast-like cells express platelet-derived growth factor receptor alpha in the murine gastrointestinal musculature. Histochem Cell Biol (2009) 2.06
Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer (2014) 2.00
Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol (2009) 1.79
Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano (2011) 1.74
Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev Cell (2009) 1.61
Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res (2005) 1.47
Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2006) 1.42
Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. Nano Lett (2012) 1.40
Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials. ACS Nano (2012) 1.39
Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ. Part Fibre Toxicol (2006) 1.39
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest (2010) 1.38
Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 1.37
Imatinib attenuates skeletal muscle dystrophy in mdx mice. FASEB J (2009) 1.30
Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. Cell Signal (2008) 1.28
Toll-like receptors, wound healing, and carcinogenesis. J Mol Med (Berl) (2008) 1.27
Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol (2006) 1.26
Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One (2013) 1.26
Molecular serum markers of liver fibrosis. Biomark Insights (2012) 1.20
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med (2011) 1.18
Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am J Respir Cell Mol Biol (2009) 1.18
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis. Fibrogenesis Tissue Repair (2010) 1.17
Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest (2009) 1.15
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev (2011) 1.14
Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair (2008) 1.13
A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene (2009) 1.13
Relationship between interstitial cells of Cajal, fibroblast-like cells and inhibitory motor nerves in the internal anal sphincter. Cell Tissue Res (2011) 1.09
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum (2011) 1.08
Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol (2011) 1.07
Roles for CCN2 in normal physiological processes. Cell Mol Life Sci (2011) 1.06
Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) (2012) 1.06
The possible potential therapeutic targets for drug induced gingival overgrowth. Mediators Inflamm (2013) 1.06
Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts. Fibrogenesis Tissue Repair (2011) 1.05
Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. Am J Pathol (2008) 1.04
Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis. Am J Pathol (2005) 1.03
Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiat Oncol (2009) 1.03
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Eur Respir J (2015) 1.03
Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling. Int J Inflam (2011) 1.02
Can renal fibrosis be reversed? Pediatr Nephrol (2005) 1.02
Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia. Exp Lung Res (2007) 1.02
Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Respir Res (2014) 1.01
Nuclear factor I-C links platelet-derived growth factor and transforming growth factor beta1 signaling to skin wound healing progression. Mol Cell Biol (2009) 1.00
Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology (2012) 1.00
Platelet-derived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol (2011) 0.99
The wound healing, chronic fibrosis, and cancer progression triad. Physiol Genomics (2014) 0.99
PDGFRα signaling drives adipose tissue fibrosis by targeting progenitor cell plasticity. Genes Dev (2015) 0.99
Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling. Am J Pathol (2009) 0.98
Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med (2010) 0.98
Phf14, a novel regulator of mesenchyme growth via platelet-derived growth factor (PDGF) receptor-α. J Biol Chem (2012) 0.97
Gene transcriptional networks integrate microenvironmental signals in human breast cancer. Integr Biol (Camb) (2010) 0.96
Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family. Mediators Inflamm (2015) 0.96
Emerging role of HMGB1 in fibrotic diseases. J Cell Mol Med (2014) 0.94
The PDGF family in renal fibrosis. Pediatr Nephrol (2011) 0.94
Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle. Front Aging Neurosci (2014) 0.93
Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD. J Ophthalmol (2016) 0.92
Proximal tubule-specific overexpression of netrin-1 suppresses acute kidney injury-induced interstitial fibrosis and glomerulosclerosis through suppression of IL-6/STAT3 signaling. Am J Physiol Renal Physiol (2013) 0.92
An Akt- and Fra-1-dependent pathway mediates platelet-derived growth factor-induced expression of thrombomodulin, a novel regulator of smooth muscle cell migration. Am J Pathol (2010) 0.92
PDGF-Ralpha gene expression predicts proliferation, but PDGF-A suppresses transdifferentiation of neonatal mouse lung myofibroblasts. Respir Res (2009) 0.91
A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp Biol Med (Maywood) (2015) 0.91
Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment. Fibrogenesis Tissue Repair (2010) 0.90
Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy. J Pharmacol Exp Ther (2014) 0.90
Up-regulation of RACK1 by TGF-β1 promotes hepatic fibrosis in mice. PLoS One (2013) 0.90
Lung involvement in systemic sclerosis. Presse Med (2010) 0.90
Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med (2014) 0.90
Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respir Res (2011) 0.89
Possible strategies for anti-fibrotic drug intervention in scleroderma. J Cell Commun Signal (2011) 0.89
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr (2014) 0.89
Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activation. Am J Respir Cell Mol Biol (2012) 0.88
The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices. PLoS One (2014) 0.87
Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein. PLoS One (2013) 0.87
ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. Am J Physiol Cell Physiol (2014) 0.87
Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis. PLoS One (2014) 0.86
Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair. Fibrogenesis Tissue Repair (2014) 0.86
Luminescent detection of DNA-binding proteins. Nucleic Acids Res (2011) 0.86
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis. Front Pharmacol (2016) 0.86
Suramin alleviates glomerular injury and inflammation in the remnant kidney. PLoS One (2012) 0.85
Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia (2016) 0.85
Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis. Am J Physiol Cell Physiol (2015) 0.84
Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy. J Pharmacol Exp Ther (2011) 0.84
Transient receptor potential (TRP) channels and cardiac fibrosis. Curr Top Med Chem (2013) 0.84
Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression. J Am Soc Nephrol (2015) 0.84
Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery. Crit Care (2013) 0.83
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib. Drug Des Devel Ther (2013) 0.83
B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin. Arthritis Res Ther (2012) 0.83
Innate Immune Responses to Nanoparticle Exposure in the Lung. J Environ Immunol Toxicol (2015) 0.83
Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells. Stem Cells Int (2012) 0.82
Structural and functional properties of platelet-derived growth factor and stem cell factor receptors. Cold Spring Harb Perspect Biol (2013) 0.82
PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation. J Cell Sci (2012) 0.81
State of the art. Bronchiolitis in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.81
Identification of platelet-derived growth factor D in human chronic allograft nephropathy. Hum Pathol (2008) 0.81
Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol (2014) 0.80
Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis. J Histochem Cytochem (2008) 0.80